業績

2025,Kobayashi K, Inaba Y, Hashimoto M, Maeda H. Cross-sectional Study and Comparison between Japan and the United States on Special Regulatory Pathways for Expedited Drug Development and Approval. Therapeutic Innovation & Regulatory Science. 2025. https://doi.org/10.1007/s43441-025-00771-5.

https://link.springer.com/article/10.1007/s43441-025-00771-5